Antimicrobial Wound Dressings Market size was over USD 1.81 billion in 2024 and is projected to reach USD 4.1 billion by 2037, growing at around 6.5% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of antimicrobial wound dressings is evaluated at USD 1.9 billion. The market is expanding due to the rising prevalence of chronic wounds. For instance, it is speculated that over 13 million people worldwide suffer from chronic wounds each year, with the number of sufferers increasing as the population ages.
Antibacterial wound dressings contain agents or compounds with antibacterial characteristics, such as silver, iodine, and PHM. Antimicrobial wound dressings, which act as a barrier against microorganisms, can minimize the risk of infection and facilitate healing. Therefore, the global frequency of chronic wounds is predicted to rise, increasing the demand for antimicrobial wound dressings.
In addition to this, the antimicrobial wound dressings market is observing tremendous growth owing to the improved understanding of the wound healing process and technological advancements, there have been noteworthy advances in wound treatment. Along with this, dressings made from natural and synthetic sources are currently gaining popularity. Plant extracts have been successfully studied in injectable forms for adult stem cell therapies, and they have been shown to aid in skin regeneration when used in dressings.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.5% |
|
Base Year Market Size (2024) |
USD 1.81 billion |
|
Forecast Year Market Size (2037) |
USD 4.1 billion |
|
Regional Scope |
|
Application (Chronic Wounds, Acute Wounds)
The chronic wounds segment in the antimicrobial wound dressings market is estimated to gain the largest revenue share of about 58% in the year 2037. The dominance can be linked to an increase in the number of persons suffering from chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other types. Diabetes, cancer, and other autoimmune illnesses are expected to increase the incidence rate of chronic wounds all over the world. Diabetes risk factors include age, diet, physical activity, obesity, and genetics.
High blood sugar levels, poor circulation, immune system issues, and nerve damage can all increase the risk of developing a chronic wound, such as a diabetic foot ulcer. For instance, approximately 25% of patients with diabetes will develop a foot ulcer. A foot ulcer is the starting point for 85% of diabetic amputations.
Also, neuropathy, peripheral arterial disease (PAD), deformities, and Charcot's foot are all risk factors for developing diabetic foot ulcers. Therefore, these factors are boosting the growth of the market in this segment.
Product (Silver Dressings, Povidone-iodine Dressings, PHMB Dressings)
The silver dressings segment is predicted to hold a substantial share of 50% during the forecast timeline. The segment’s growth is driven by growing demand for the treatment of infections and wounds. Silver wound dressings are antimicrobial wound dressings using silver as an active ingredient. The dressing acts by releasing silver ions, which help to kill or inhibit the development of bacteria in the wound bed.
In the treatment of chronic wounds that are prone to infection, such as pressure ulcers and diabetic foot ulcers, silver wound dressing is helpful. They are also used to treat surgical wounds, lowering the risk of infection and promoting speedier recovery. Therefore, these factors are impacting the growth of the silver dressing segment.
Our in-depth analysis of the market includes the following segments:
|
Product |
|
|
Application |
|
|
End-use |
|
North America Market Statistics
Antimicrobial Wound Dressings market in the North America, amongst the market in all the other regions, is set to hold the largest with a share of about 37% by the end of 2037. The market growth in the region is also expected on account of a large aging population, increased wound and injury rates, and a high incidence of diabetes. According to a report, chronic wounds afflict around 8.2 million people in the United States every year.
Additionally, the region’s market is predicted to expand due to rising healthcare costs and expanded government support and reimbursement schemes for goods. Moreover, North America has well-established healthcare legislation and infection control requirements, making antimicrobial dressings an appealing option for healthcare professionals. These criteria place a high priority on avoiding surgical site infections, pressure ulcers, and other problems that can be treated with antimicrobial dressings.
APAC Market Analysis
The APAC region will also witness gigantic growth for the antimicrobial wound dressings market during the forecast period and will hold the second position owing to the expanding population in the region. Furthermore, medical tourism and an increase in severe wounds are major factors augmenting the market growth in the region. Antimicrobial wound dressings may also become more popular as chronic diseases and surgical cases increase in the Asia-Pacific region.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?